FDAClass II · Drug · Recalled May 6, 2026

Optase Dry Eye Intense Drops (Glycerin 0 recall — SCOPE HEALTH

Hazard: Lack of Assurance of Sterility

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID: D-0499-2026
Brand: SCOPE HEALTH
Classification: Class II
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Description

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.

Affected products

Optase Dry Eye Intense Drops (Glycerin 0

Companies & origin

Recalling firm location: New York, NY, United States
Firm address: 79 Madison Avenue, 27 E 28th St, 10016-7921

Identifying details (verbatim from the notice)

Product codes / lots: Lot#: 8T98, 9T31, 9T32, Exp. Date: 30/04/26; 2V13, 2V14, 2V15, Exp. Date 30/06/26; 3V35, Exp. Date 31/08/26;3V36, 3V37, Exp. Date 30/09/26; 5V45, 5V46, 9V12, Exp. Date 31/03/27; 1X57, 1X70, 1X84, Exp. Date 31/05/27.
Distribution: Nationwide within the United States
Firm notified the public via: Letter
FDA event ID: 98802
Recall initiated: April 20, 2026
FDA classified: April 28, 2026
FDA report date: May 6, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 12:00 AM UTC.

Report a data error on this page